195 related articles for article (PubMed ID: 12917168)
1. Incidence of exudative age-related macular degeneration among elderly Americans.
Javitt JC; Zhou Z; Maguire MG; Fine SL; Willke RJ
Ophthalmology; 2003 Aug; 110(8):1534-9. PubMed ID: 12917168
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
3. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
[TBL] [Abstract][Full Text] [Related]
4. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
Klein R; Klein BE; Tomany SC; Cruickshanks KJ
Ophthalmology; 2003 Jun; 110(6):1273-80. PubMed ID: 12799274
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
6. Age-related macular degeneration is associated with an increased risk of hip fractures in the Medicare database.
Anastasopoulos E; Yu F; Coleman AL
Am J Ophthalmol; 2006 Dec; 142(6):1081-3. PubMed ID: 17157603
[TBL] [Abstract][Full Text] [Related]
7. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
Coleman AL; Yu F
Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
[TBL] [Abstract][Full Text] [Related]
8. Age-related macular degeneration in Singapore.
Cheng CL; Saw SM; Pang CE; Chee C
Singapore Med J; 2009 Feb; 50(2):126-31. PubMed ID: 19296026
[TBL] [Abstract][Full Text] [Related]
9. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
Alexander SL; Linde-Zwirble WT; Werther W; Depperschmidt EE; Wilson LJ; Palanki R; Saroj N; Butterworth SL; Ianchulev T
Ophthalmology; 2007 Dec; 114(12):2174-8. PubMed ID: 18054636
[TBL] [Abstract][Full Text] [Related]
10. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes.
Song SJ; Youm DJ; Chang Y; Yu HG
Ophthalmic Epidemiol; 2009; 16(5):304-10. PubMed ID: 19874110
[TBL] [Abstract][Full Text] [Related]
11. Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population.
Zlateva GP; Javitt JC; Shah SN; Zhou Z; Murphy JG
Retina; 2007; 27(9):1292-9. PubMed ID: 18046240
[TBL] [Abstract][Full Text] [Related]
12. Five-year incidence of age-related maculopathy: the Visual Impairment Project.
Mukesh BN; Dimitrov PN; Leikin S; Wang JJ; Mitchell P; McCarty CA; Taylor HR
Ophthalmology; 2004 Jun; 111(6):1176-82. PubMed ID: 15177968
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
14. New treatments for age-related macular degeneration.
Mittra RA
Minn Med; 2003 Apr; 86(4):40-6. PubMed ID: 12797657
[TBL] [Abstract][Full Text] [Related]
15. Population-based incidence of exudative age-related macular degeneration and ranibizumab treatment load.
Geirsdottir A; Jonsson O; Thorisdottir S; Helgadottir G; Jonasson F; Stefansson E; Sigurdsson H
Br J Ophthalmol; 2012 Mar; 96(3):444-7. PubMed ID: 21856691
[TBL] [Abstract][Full Text] [Related]
16. Older women with age-related macular degeneration have a greater risk of falls: a physiological profile assessment study.
Szabo SM; Janssen PA; Khan K; Potter MJ; Lord SR
J Am Geriatr Soc; 2008 May; 56(5):800-7. PubMed ID: 18363677
[TBL] [Abstract][Full Text] [Related]
17. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
[TBL] [Abstract][Full Text] [Related]
18. Recent statin use and 1-year incidence of exudative age-related macular degeneration.
Fong DS; Contreras R
Am J Ophthalmol; 2010 Jun; 149(6):955-958.e1. PubMed ID: 20346439
[TBL] [Abstract][Full Text] [Related]
19. The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.
Tournier M; Moride Y; Lesk M; Ducruet T; Rochon S
Can J Clin Pharmacol; 2008; 15(1):e22-35. PubMed ID: 18579928
[TBL] [Abstract][Full Text] [Related]
20. Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort.
Reeves SW; Sloan FA; Lee PP; Jaffe GJ
Ophthalmology; 2006 Feb; 113(2):307.e1. PubMed ID: 16406541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
